Early research (Phase 1)Study completedNCT05769049
What this trial is testing
The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)
Who this might be right for
Herpes Zoster
Jiangsu Rec-Biotechnology Co., Ltd. 48
Showing 20 of 0 results